Press Release

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Cancer Screening Market to Grow at a CAGR of 9% During 2021-2026, Driven by Technological Advancements

According to a new report by EMR titled, ‘Global Cancer Screening Market Report and Forecast 2021-2026’, the market is expected to grow at a CAGR of 9% in the forecast period of 2021-2026.

The rising initiatives to reduce the number of fatalities caused by cancer are aiding the industry growth. The increasing research and development (R&D) due to the rising investments by the government and various other organisations to promote awareness about cancer while developing advanced and efficient treatments. For instance, Centres for Disease Control and Prevention (CDC) invested USD 145 million in cancer screening while initiating a campaign called “Screen for Life”; such developments positively impact the cancer screening industry. In addition, the rising demand for effective screening without dangerous side effects can propel the market growth in the forecast period. Furthermore, the rising awareness about the benefits of early detection in both developed and emerging countries are significantly contributing to the cancer screening industry.

Epigenomics AG (FRA: ECX), one of the leading players in the market, unveiled its next-generation liquid biopsy test for colorectal cancer screening in January 2021. The screening is built on the company’s expertise in liquid biopsy and DNA methylation biomarkers. Moreover, the algorithm for the screening was trained in a study with 454 samples comprising CRC patients and clinical controls. Additionally, this nest generation multi-target real-time PCR blood test is based on a new proprietary core DNA methylation technology that provides valid results for greater than 99% of samples analysed and a fast, easy to use and affordable option for detecting CRC in a liquid biopsy. The development of such products is anticipated to provide impetus to the market growth in the forecast period.

Market Analysis by Cancer Type, Technique, Stage, Gender, and Region:

  • The market on the basis of cancer type can be divided into lung cancer, blood cancer, bone cancer, gall bladder cancer, testicular cancer, thyroid cancer, and breast cancer, among others.
  • Based on technique, the industry can be divided into imaging techniques, endoscopy, biopsy and cytology tests, and genomic and molecular tests.
  • The stages for cancer screening include TNM stages, stages 0, 1, 2, 3, 4, and prognostic factors, among others.
  • On the basis of gender, the market is segmented into men and women.
  • The regional markets for cancer screening include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The surge of cancer cases around the world due to unhealthy lifestyles and the presence of carcinogenic products are aiding the market growth.
  • The market is being driven by the rising awareness of cancer and the increasing initiatives by various governments to prevent serious illnesses and deaths from the disease.
  • The development of various advanced and innovative technologies, which can diagnose cancer without any major side effects is propelling the industry growth.
  • Increasing research and development (R&D) to prevent and cure cancer effectively as well as diagnose cancers, such as leukaemia and ovarian cancer, are catalysing the market growth.

Key Offerings of the Report:

  • The EMR report gives an overview of the global cancer screening market for the periods (2016-2020) and (2021-2026).
  • The report also offers the historical (2016-2020) and forecast (2021-2026) markets for the cancer types, techniques, stages, gender, and regions of cancer screening.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global market for cancer screening are DiaSorin S.p.A., Epigenomics AG, Techlab, Inc., Positive Biosciences Limited, MedGenome Labs Ltd, and 20/20 GeneSystems, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER